{
  "scenario_id": "strategic_acquisition_2025",
  "context": "Healthcare technology company, 200 employees, pursuing acquisition to accelerate AI diagnostics platform development",
  "stakeholders": {
    "requester": "CEO",
    "approvers": [
      "Board of Directors",
      "Major Investors"
    ],
    "influencers": [
      "CFO",
      "Chief Medical Officer",
      "Legal Counsel",
      "Integration Team"
    ]
  },
  "request": {
    "amount": "$15,000,000",
    "purpose": "Acquire AI diagnostics startup with proprietary algorithms and clinical validation data",
    "urgency": "high",
    "justification": "Target company has 3-year development lead and validated IP that could reduce time-to-market by 18 months"
  },
  "decision_process": [
    {
      "stage": "target_evaluation",
      "duration": "10 weeks",
      "activities": [
        "Due diligence (technical, financial, legal)",
        "Synergy analysis",
        "Cultural assessment",
        "Integration planning"
      ],
      "outcome": "Strong strategic fit confirmed"
    },
    {
      "stage": "valuation_negotiation",
      "duration": "6 weeks",
      "activities": [
        "Financial modeling",
        "Term sheet negotiation",
        "Regulatory approval planning",
        "Financing arrangements"
      ],
      "outcome": "Agreed valuation with earn-out provisions"
    },
    {
      "stage": "board_approval",
      "duration": "2 weeks",
      "activities": [
        "Final presentation",
        "Risk review",
        "Strategic alignment confirmation",
        "Voting process"
      ],
      "outcome": "Approved with integration milestones"
    }
  ],
  "business_impact": {
    "expected_revenue_synergies": "$5,000,000 annually",
    "time_to_market_acceleration": "18 months saved",
    "risk_factors": [
      "Integration challenges",
      "Key personnel retention",
      "Technology integration complexity"
    ],
    "strategic_value": "Market leadership in AI diagnostics with expanded clinical applications"
  }
}